Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Ortho Clinical Diagnostics stock

Learn how to easily invest in Ortho Clinical Diagnostics stock.

Ortho Clinical Diagnostics Holdings plc is a diagnostics & research business based in the US. Ortho Clinical Diagnostics shares (OCDX) are listed on the NASDAQ and all prices are listed in US Dollars. Ortho Clinical Diagnostics employs 4,500 staff and has a trailing 12-month revenue of around $1.9 billion.

How to buy shares in Ortho Clinical Diagnostics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OCDX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Ortho Clinical Diagnostics stock price (NASDAQ: OCDX)

Use our graph to track the performance of OCDX stocks over time.

Ortho Clinical Diagnostics shares at a glance

Information last updated 2021-05-26.
Latest market close$17.63
52-week range$15.14 - $21.82
50-day moving average $19.71
200-day moving average $18.56
Wall St. target price$24.82
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Ortho Clinical Diagnostics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ortho Clinical Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ortho Clinical Diagnostics price performance over time

Historical closes compared with the close of $17.63 from 2022-05-26

1 week (2022-09-17) N/A
1 month (2022-08-24) N/A
3 months (2022-06-24) N/A
6 months (2022-03-28) -4.13%
1 year (2021-09-27) -5.11%
2 years (2020-09-24) N/A
3 years (2019-09-24) N/A
5 years (2017-09-24) N/A

Is Ortho Clinical Diagnostics stock undervalued or overvalued?

Valuing Ortho Clinical Diagnostics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ortho Clinical Diagnostics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ortho Clinical Diagnostics's EBITDA

Ortho Clinical Diagnostics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $438.9 million.

The EBITDA is a measure of a Ortho Clinical Diagnostics's overall financial performance and is widely used to measure a its profitability.

To put Ortho Clinical Diagnostics's EBITDA into context you can compare it against that of similar companies.

Ortho Clinical Diagnostics financials

Revenue TTM $1.9 billion
Operating margin TTM 8.34%
Gross profit TTM $880.4 million
Return on assets TTM 1.97%
Return on equity TTM 0%
Profit margin -8.03%
Book value N/A
Market capitalisation $4.7 billion

TTM: trailing 12 months

Shorting Ortho Clinical Diagnostics shares

There are currently 2.7 million Ortho Clinical Diagnostics shares held short by investors – that's known as Ortho Clinical Diagnostics's "short interest". This figure is 10.4% up from 2.4 million last month.

There are a few different ways that this level of interest in shorting Ortho Clinical Diagnostics shares can be evaluated.

Ortho Clinical Diagnostics's "short interest ratio" (SIR)

Ortho Clinical Diagnostics's "short interest ratio" (SIR) is the quantity of Ortho Clinical Diagnostics shares currently shorted divided by the average quantity of Ortho Clinical Diagnostics shares traded daily (recently around 869855.22875817). Ortho Clinical Diagnostics's SIR currently stands at 3.06. In other words for every 100,000 Ortho Clinical Diagnostics shares traded daily on the market, roughly 3060 shares are currently held short.

To gain some more context, you can compare Ortho Clinical Diagnostics's short interest ratio against those of similar companies.

    However Ortho Clinical Diagnostics's short interest can also be evaluated against the total number of Ortho Clinical Diagnostics shares, or, against the total number of tradable Ortho Clinical Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ortho Clinical Diagnostics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Ortho Clinical Diagnostics shares in existence, roughly 10 shares are currently held short) or 0.0294% of the tradable shares (for every 100,000 tradable Ortho Clinical Diagnostics shares, roughly 29 shares are currently held short).

    Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ortho Clinical Diagnostics.

    Find out more about how you can short Ortho Clinical Diagnostics stock.

    Ortho Clinical Diagnostics share dividends

    We're not expecting Ortho Clinical Diagnostics to pay a dividend over the next 12 months.

    Ortho Clinical Diagnostics overview

    Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company also engages in contract manufacturing activities; and provides orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. The company was founded in 1939 and is headquartered in Raritan, New Jersey. .

    Frequently asked questions

    What percentage of Ortho Clinical Diagnostics is owned by insiders or institutions?
    Currently 0.453% of Ortho Clinical Diagnostics shares are held by insiders and 99.59% by institutions.
    How many people work for Ortho Clinical Diagnostics?
    Latest data suggests 4,500 work at Ortho Clinical Diagnostics.
    When does the fiscal year end for Ortho Clinical Diagnostics?
    Ortho Clinical Diagnostics's fiscal year ends in December.
    Where is Ortho Clinical Diagnostics based?
    Ortho Clinical Diagnostics's address is: 1001 Route 202, Raritan, NJ, United States, 08869

    More guides on Finder

    Ask an Expert

    You are about to post a question on

    • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
    • is a financial comparison and information service, not a bank or product provider
    • We cannot provide you with personal advice or recommendations
    • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

    By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

    Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
    Go to site